©2007 UpToDate®
Comparison of recommendations of published guidelines for empiric antimicrobial therapy of community-acquired pneumonia in adults (from North America, United Kingdom)
Guideline Site of care
Outpatient General ward ICU/severe
EEUU Guide (ATS/IDSA; 2007) [1]

If no significant risks for DRSP*:
Macrolide[Delta] or doxycycline

If risks for DRSP*:
Antipneumococcal fluoroquinolone[Bullet]

OR

High-dose amoxicillin (3 gm/day) or high dose amoxicillin/clavulanate (4 gm/day) plus macrolide (if amoxicillin is used and there is a concern for H. influenzae, use macrolide active for [Beta]-lactamase producing strains)

OR

Telithromycin[Lozenge]

[Beta]-lactam (ceftriaxone, cefotaxime, ampicillin/sulbactam, ertapenem) plus macrolide (can use doxycycline if macrolide not tolerated)

OR

Antipneumococcal fluoroquinolone[Bullet] alone

[Beta]-lactam (ceftriaxone, cefotaxime, ampicillin/sulbactam) plus IV azithromycin or IV fluoroquinolone[Bullet]

If concern for Pseudomonas (eg, presence of structural lung disease such as bronchiectasis): antipseudomonal agent (piperacillin/tazobactam, imipenem, meropenem, or cefepime) plus antipseudomonal fluoroquinolone (ciprofloxacin or high dose levofloxacin);

If concern for MRSA (see text): add vancomycin or linezolid

British Thoracic Society (2004) [2] Amoxicillin 500-1000 mg thrice daily; (Alternative therapy: erythromycin or clarithromycin)

If admitted for non-clinical reasons or previously untreated in the community:
Amoxicillin (macrolide as alternative)

If admitted for pneumonia and oral therapy appropriate:
Amoxicillin plus (erythromycin or clarithromycin); (Alternative therapy: antipneumococcal fluoroquinolone[Bullet])

If parenteral therapy appropriate:
Ampicillin or benzylpenicillin plus (erythromycin or clarithromycin); (Alternative therapy: IV levofloxacin, note IV moxifloxacin not available in UK)

Co-amoxiclav or 2nd/3rd generation cephalosporin plus (IV erythromycin or clarithromycin, +/- rifampin); (IV levofloxacin plus IV benzylpenicillin as alternative)
ICU: intensive care unit; DRSP: drug resistant S. pneumoniae; UK: United Kingdom; IV: intravenous.
* Antimicrobial therapy within the past 3 months, hospitalization within the past month, alcoholism, immune-suppressive illness (including therapy with corticosteroids), multiple medical comorbidities, exposure to a child in a day care center.
[Bullet] Gemifloxacin, Levofloxacin, Moxifloxacin (Gemifloxacin is only available in oral formulation).
[Delta] Azithromycin or clarithromycin.
[Lozenge] Rare cases of severe liver failure reported.
1. Clin Infect Dis. 2007.
2. British Thoracic Society. Pneumonia Guidelines Committee (John MacFarlane, Chair). Guidelines for the management of community-acquired pneumonia-2004 Update. www.Brit-thoracic.org/guideline.

©2007 UpToDate®www.uptodate.com
Licensed to Fundacion Hospital De Manacor